Innovative Screening Approaches for Early Detection of MS supports research teams developing and validating practical tests to identify likely MS cases in risk-enriched groups and speed neurological evaluation.
The National Multiple Sclerosis Society’s Commercial Research Funding Opportunity supports innovative research to develop new MS therapies and diagnostics, bridging discovery and commercial development.
Research Grants support investigators pursuing fundamental and applied MS research to advance roadmap goals of stopping disease activity, restoring function, and preventing new cases of MS.
Funding for innovative methods to screen and treat potentially fatal disorders in newborns, including genetic conditions needing screening advancements.
Neuroimaging and CSF Biomarkers supports researchers and clinicians developing and validating biomarkers to advance drug development, diagnosis, and monitoring for Alzheimer's disease and related dementias.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.